XLU News 42.83 07/14/2014 05:50:44 Utilities Select Sector SPDR

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Utilities Select Sector SPDR (XLU) 42.83 $XLU

Russell 2000 Stays Down for the Day and Year as Majors Gain
at The Street - Fri Jul 11, 5:12PM CDT
The stock market was higher on Friday in slow trading, but the Russell 2000 was again on the downside and negative for the 2014. This is a red flag.

Can Utility ETFs Regain Their Lost Momentum? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jul 09, 11:00AM CDT
Utility ETFs were star performers to begin the year, but they have stumbled lately. Can they turn it around in the second half of 2014?

How to Reap Big Dividends From the Utilities Sector
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jul 07, 4:45PM CDT
Source: DTEEnergy.com. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some utility companies to your portfolio but don't have the time or expertise to hand-pick a few, the ...

Utilities, Energy, Health Care Are the ETFs to Beat This Year
at The Street - Thu Jul 03, 10:10AM CDT
I track 11 exchange-traded funds, and the best year-to-date performer is utilities, while health care set an all-time high on Wednesday.

'Fast Money' Recap: Let Your Winning Trades Keep Running
at The Street - Wed Jul 02, 4:00AM CDT
The trading panel discussed yet another closing high for the S&P 500 and DJIA plus what they are buying and selling.

Why NextEra Energy's Momentum Will Continue Into the Third Quarter
at The Street - Tue Jul 01, 5:00AM CDT
Over the last six quarters, the stock has closed higher after reporting earnings.

This U.S. Stock Market Is Not Dealing in Reality as It Moves Higher
at The Street - Mon Jun 30, 4:32PM CDT
The stock market on Monday closed out the second quarter in mixed fashion. The DJIA is oversold while the Nasdaq is overbought.

XLU, PCG, PPL, PEG: ETF Inflow Alert
ETFChannel.com - Thu Jun 26, 10:03AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Utilities Select Sector SPDR Fund where we have detected an approximate $606.6 million dollar inflow -- that's a 9.8%...

A Stock Market Selloff With Some Volume and Power Behind It
at The Street - Tue Jun 24, 4:20PM CDT
The stock indexes closed down on Tuesday after an intraday turn from the upside. The downside volume was big in comparison to the upside volume for the past month.

Trading Index ETFs: Semiconductors and Utilities Are in the Lead
at The Street - Fri Jun 20, 9:23AM CDT
Among eight exchange-traded funds that track major market indices, the headliners are the ones that track semiconductors, utilities and transports.

Can the Stock Market Continue to Rise With Contrary Indicators?
at The Street - Thu Jun 19, 4:40PM CDT
The stock market continues to go higher against the backdrop of accelerating inflation and growth slowing indicators. What will ultimately stop the advance?

A Comprehensive Guide to Utility ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 11:25AM CDT
Utility ETFs can be good options for investors looking for defensive investments with solid cash flows.

Janet Yellen Speaks and Up Goes the S&P 500: Mission Accomplished
at The Street - Wed Jun 18, 4:49PM CDT
This overheated, bubble like stock market continues to go higher on the heels of the Federal Reserve Chairperson, Janet Yellen, giving the green light to buy stocks.

The Birth, Growth, Maturity and Death of the Current Bull Market
at The Street - Tue Jun 17, 4:30PM CDT
This bull market is getting very close to the end. It cannot continue.

Market Bears Make It Two in a Row Despite Increased Volume
at The Street - Thu Jun 12, 4:22PM CDT
Could this be the start of something bigger or just short-term profit-taking by the bulls?

Powerhouse ETFs: Transports and Technology Are the Best Performers
at The Street - Thu Jun 12, 10:58AM CDT
I continue to track 11 Exchange Traded Funds as a conservative way to invest in specific sectors of the stock market in an environment where stock-picking remains difficult.

This Dividend-Stock Mistake Can Ruin Your Retirement
Dan Caplinger, The Motley Fool - Motley Fool - Sat Jun 07, 6:25AM CDT
Dividend stocks are an essential part of retiring with financial security. But many retirees make a very simple and avoidable mistake with their dividend stocks: they choose the highest-yielding stocks available rather than thinking about longer-term...

3 Sector ETFs for This Shaky Market - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri May 16, 9:02AM CDT
If you are looking for stability, try these sector ETFs on for size.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading